Plunkett Research Online: RespireRx Pharmaceuticals Inc

RESPIRERX PHARMACEUTICALS INC (RSPI:OTCM) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

RespireRx Pharmaceuticals Inc is engaged in the discovery, value-added development, and commercialization through partners of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is in a 505(b)(2) development ideas for.....



RespireRx Pharmaceuticals Inc
Ticker: RSPI
Exchange: OTCM
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 201-444-4947
Fax:
Address: 126 Valley Road
Suite C
Glen Rock, NJ 07452 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Neurological
Drug Development
Pharmaceutical Cannabinoids
Neuromodulators
Contacts Description
Maria MessingerCFO/Chief Accounting Officer/Secretary/Vice President
Roger StollChairman of the Board/Director
See More
RespireRx Pharmaceuticals Inc is engaged in the discovery, value-added development, and commercialization through partners of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is in a 505(b)(2) development ideas for.....See More See More

Auditor: Haskell & White LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
ResolutionRx
EndeavourRx
AMPAkines
GABAkines
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: